Inventor · disambiguated record
Raphael Rozenfeld
Also filed as: ROZENFELD RAPHAEL
9 granted patents·5 pending applications·19 citations·filing 2011–2022
84Inventor score
Top patents by PatentIndex Score
14 records- 0195US11053294B2Masked cytokine polypeptidesXILIO DEV INC·Filed 2020·Granted Jul 6, 2021·13 cites·15 claims
- 0292US11866476B2Masked IL-2-Fc fusion polypeptidesXILIO DEV INC·Filed 2022·Granted Jan 9, 2024·1 cites·10 claims
- 0390US11718655B2Masked interleukin-12 polypeptidesXILIO DEV INC·Filed 2022·Granted Aug 8, 2023·1 cites·9 claims
- 0476US9216189B2Antibodies which bind type I cannabinoid receptor/angiotensis II receptor heteromersDEVI LAKSHMI A·Filed 2011·Granted Dec 22, 2015·3 cites·2 claims
- 0575US11827686B2Masked cytokine polypeptidesXILIO DEV INC·Filed 2021·Granted Nov 28, 2023·0 cites·9 claims
- 0675US11827685B2Masked cytokine polypeptidesXILIO DEV INC·Filed 2021·Granted Nov 28, 2023·0 cites·18 claims
- 0774US2022002370A1Masked cytokine polypeptidesXILIO DEV INC·Filed 2019·Application pending·0 cites
- 0873US9855290B2Antibodies which bind type I cannabinoid receptor/angiotensin II receptor heteromers and methods of useICAHN SCHOOL MED MOUNT SINAI·Filed 2015·Granted Jan 2, 2018·1 cites·10 claims
- 0968US11141423B2Methods of screening compounds useful for treatment of a liver diseaseICAHN SCHOOL MED MOUNT SINAI·Filed 2019·Granted Oct 12, 2021·0 cites·4 claims
- 1060US2018250322A1Antibodies which bind type i cannabinoid receptor/angiotensis ii receptor heteromersICAHN SCHOOL MED MOUNT SINAI·Filed 2017·Application pending·0 cites
- 1154US12280120B2Tumor-specific cleavable linkersXILIO DEV INC·Filed 2021·Granted Apr 22, 2025·0 cites·11 claims
- 1249US2023331799A1Masked il-15 cytokines and their cleavage productsXILIO DEV INC·Filed 2021·Application pending·0 cites
- 1349US2023159603A1Masked il-12 cytokines and their cleavage productsXILIO DEV INC·Filed 2021·Application pending·0 cites
- 1449US2023151072A1Masked il-2 cytokines and their cleavage productsXILIO DEV INC·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →